GPCR Targeting Drugs
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
180
NCT06616974
A Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (the APEX Study)
Phase: Phase 2
Role: Lead Sponsor
Start: Oct 8, 2024
Completion: Nov 20, 2026
Loading map...